Standout Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2023 2026 2024145
  1. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2023)
    Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine

Immediate Impact

9 standout
Sub-graph 1 of 3

Citing Papers

Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
2 intermediate papers

Works of Peter M. Irving being referenced

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout

Author Peers

Author Last Decade Papers Cites
Peter M. Irving 140 109 40 45 12 158
E. García‐Planella 187 173 51 48 16 234
Luca Ferraris 162 128 73 32 10 210
Antonio López-Sanromán 88 75 72 56 12 205
Luisa de Castro 156 130 51 25 8 170
Laura Loy 95 62 35 45 22 144
Laura Cantoro 102 83 70 26 9 158
Alexandros Skamnelos 84 64 48 22 13 137
Juan E. Naves 98 93 74 21 15 192
Maria de Lourdes Abreu Ferrari 93 96 85 44 16 214
Sai Wei Chuah 151 119 60 74 12 230

All Works

Loading papers...

Rankless by CCL
2026